The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a new study conducted by researchers at King's College London (KCL ...

AZ said Fasenra (benralizumab) has been approved as an add-on maintenance treatment in adults with severe eosinophilic asthma, inadequately controlled on standard inhaled corticosteroid and long ...

Eosinophilic esophagitis (EoE) is a rare inflammatory disease of the esophagus, the tube that connects your mouth to your stomach. If you have EoE, a type of white blood cell known as an ...

LONDON — AstraZeneca’s AZN.L Fasenra, an injectable treatment ... for a severe form of the breathing disorder called eosinophilic asthma that targets a type of white blood cell associated ...

Eosinophilic granulomatosis with polyangiitis ... 8 The mechanism of action in FASENRA in asthma and EGPA has not been definitively established. The incidence of adverse reactions in the MANDARA ...

Medscape Medical News, March 20, 2020 Alert FDA OKs Asthma Drug Benralizumab (Fasenra) for At-Home Use ... aged 12 years or older who have severe eosinophilic asthma. FDA Approvals, October ...

Eosinophilic asthma (e-asthma) is a rare form of the breathing disease that can be very hard to treat successfully. That can put you in a frustrating cycle of asthma attacks. People with e-asthma ...

Interestingly, around 50% of patients with asthma also have a high number of circulating eosinophils. Patients with eosinophilic asthma tend to have more severe disease, and more frequent asthma ...

Benralizumab, which is usually know by its brand name Fasenra, was developed by MedImmune ... approved it for the treatment of severe eosinophilic asthma. Additionally, in August 2019, the FDA ...

Four medications will be impacted by the changes: Fasenra (benralizumab), used to treat adults with eosinophilic asthma. Tezspire (tezepelumab), used in combination with other asthma medications ...

Eosinophilic asthma (EA) is a type of asthma that is characterised by high levels of white blood cells, called eosinophils. AstraZeneca's injection is to be administered once in eight weeks as an ...

The RAINIER Study (NCT06496607) is an ongoing Phase IIa clinical trial investigating Solrikitug for adults with asthma. This randomized, double-blind, placebo-controlled study evaluates three dose ...